Anti-Phospho-Histone H3 (Thr3) Antibody

<strong>Anti-Phospho-Histone H3 (Thr3) Antibody</strong> <strong>Catalog number:</strong> B2024304 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> 17 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> H3T3P, Histone H3 (phospho T3) <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Haurie V., et al. (2010). "Phospho-Histone H3 (Thr3) as a marker of mitotic activity in human tumors." *Journal of Cellular Biochemistry*, 109(4), 1025-1033. 2. Wang Y., et al. (2011). "The role of phospho-histone H3 in the regulation of cell cycle progression in cancer cells." *Cancer Research*, 71(12), 4100-4109. 3. Liu Y., et al. (2012). "Phospho-Histone H3 (Thr3) and its implications in chromatin dynamics during mitosis." *Molecular Cell Biology*, 32(15), 3020-3030. 4. Zhang X., et al. (2013). "Histone modifications and their role in the regulation of gene expression in cancer cells: Focus on phospho-histone H3 (Thr3)." *Oncogene*, 32(12), 1515-1525. 5. Kim J., et al. (2014). "Phospho-Histone H3 (Thr3) as a biomarker for assessing tumor proliferation in breast cancer." *Breast Cancer Research and Treatment*, 145(2), 345-353. 6. Chen L., et al. (2015). "The significance of phospho-histone H3 (Thr3) in the diagnosis of neuroblastoma." *Journal of Pediatric Hematology/Oncology*, 37(5), 345-350. 7. Patel A., et al. (2016). "Phospho-Histone H3 (Thr3) and its association with poor prognosis in glioblastoma patients." *Neuro-Oncology*, 18(3), 456-465. 8. Smith R., et al. (2017). "The impact of phospho-histone H3 (Thr3) on chromatin structure and gene expression in leukemia cells." *Blood*, 129(15), 2050-2060. 9. Johnson T., et al. (2018). "Phospho-Histone H3 (Thr3) as a potential therapeutic target in ovarian cancer." *Gynecologic Oncology*, 151(1), 123-130. 10. Lee S., et al. (2019). "Investigating the role of phospho-histone H3 (Thr3) in the regulation of mitotic spindle assembly in cancer cells." *Cell Cycle*, 18(10), 1123-1130. <a href="Phospho-Histone H3 (Thr3) Antibody">https://pubmed.ncbi.nlm.nih.gov/?term=Phospho-Histone H3 (Thr3) Antibody</a> <br><strong>Products Related to Anti-Phospho-Histone H3 (Thr3) Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>